期刊文献+

基质金属蛋白酶(MMPs)在大动脉炎病情评估中的价值 被引量:2

The value of MMPs in evaluating disease activity of Takayasu′s arteritis
下载PDF
导出
摘要 基质金属蛋白酶(matrix metalloproteinases,MMPs)是一种锌依赖性的肽链内切酶,近来因其特有的理化作用而受到越来越多的关注。新近研究发现MMPs可以参与炎症反应、血管重构等生理病理过程,提示它可能与某些炎症相关的血管疾病如大动脉炎、动脉粥样硬化、腹主动脉瘤,甚至高血压,急性冠脉综合征等有着不容忽视的相关性。本文重点阐述MMPs的基本生化特性,其在炎症反应与血管重构中的作用以及MMPs在大动脉炎病情评估方面的的价值,希望能为临床及基础研究提供新的参考。 Matrix metalloproteinases (MMPs) are a kind of Zn-dependent endotryptase and it has special physico-chemical properties. Recent studies have demonstrated that matrix metalloproteinase could play an important role in inflammation and vascular remodeling, which indicate that it may has relationship with some inflammatory vascular diseases such as Takayasu~ s arteritis, atherosclerosis, abdominal aneurysm, even hypertension, acute coronary syndrome and so on. In this paper, we will elaborate the basic physico-chemical properties of MMPs and its role in inflammation and vascular remodeling,especially its value in evaluating the disease activity of Takayasu's arteritis.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2012年第5期541-544,共4页 Fudan University Journal of Medical Sciences
关键词 基质金属蛋白酶(MMPs) 大动脉炎 病情评估 matrix metalloproteinase (MMPs) Takayasu's arteritis assessment of disease activity
  • 相关文献

参考文献34

  • 1Gray R. Matrix metalloproteinases and their multipile roles in neurodege-nerative disease [J]. Lancet Neurol, 2009,8(2) :205 - 216.
  • 2Rath T, Roderfeld M, Graf J, et al. Matrix metalloproteinases in inflammatory bowel disease-from basic research to clinical significance[J]. Z Gastroenterol, 2009,47(8) :758 - 769.
  • 3Alvarez B, Ruiz C, Chacon P, et al. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis [J]. J Vasc Surg, 2004,40(3) :469 - 475.
  • 4Tanindi A, Sahinarslan A, Elbeg S, et al. Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion[J]. Coron Artery Dis ,2011,22 (4) :253 - 2588.
  • 5Rodriguez-Pla A, Bosch-Gil JA, Rossllo-Urgell J, et al. Metalloproteinase-2 and -9 in giant cell arteritis involvement in vascular remodeling [J]. Circulation, 2005,112(2) :264 - 269.
  • 6Derosa GC, Arrigo FG, D' Angelo A, et al. Matrix metalloproteinase-2, -9 and tissue inhibitor of metalloproteinase-l in patients with hypertension before and after Doxazosin therapy [J]. High Blood Press Cardiovasc Prey, 2006,13(2) :47 - 52.
  • 7Boyle JR, McDermott E, Crowther M, et al. Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease [J]. J Vasc Surg, 1998,27(2) :354 - 361.
  • 8Gillian M, Hideaki N. Progress in matrix metalloproteinase research [J]. MoZ Aspects Med, 2008,29 (5) :290- 308.
  • 9Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease [J]. Biochem Pharmacol, 2008,75 (2) : 346 - 359.
  • 10A1-Dasooqi N, Gibson RJ, Bowen JM, et al. Matrix metalloproteinases: key regulators in pathogenesis of chemotheraphy-induced mucositis? [J]. Cancer Chemother Pharmacol, 2009,64 (1) : 1 - 9.

同被引文献23

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部